Navigation Links
Biovista Inc. Announces Drug Repositioning Collaboration with Astellas Pharma
Date:12/2/2015

CHARLOTTESVILLE, Virginia, December 2, 2015 /PRNewswire/ --

Biovista announced today that it has entered into a drug repositioning collaboration with Astellas Pharma Inc. The collaboration is focused on identifying new indications for a number of undisclosed Astellas compounds using Biovista's Clinical Outcome Search Space (COSS) technology.

"We look forward to working with the Drug Repurposing and Application Management at Astellas to compliment their work," said Dr. Aris Persidis, President of Biovista. "Our very large scale systematic drug repositioning technology (the "Clinical Outcome Search Space - COSS(tm) offers the advantages of speed, comprehensiveness and depth of clinical outcome exploration, which we hope will help patients in need benefit even more from Astellas drugs," he added.

About Astellas:

Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. We focus on Urology, Oncology, Immunology, Nephrology and Neuroscience as prioritized therapeutic areas while advancing new therapeutic areas and discovery research leveraging new technologies/modalities. We are also creating new value by combining internal capabilities and external expertise in the medical/healthcare business. Astellas is on the forefront of healthcare change to turn innovative science into value for patients. For more information, please visit our website at http://www.astellas.com/en .

About Biovista:

Biovista is a privately held biotechnology company that finds novel uses for existing drugs, and profiles their side effects using their mechanism of action. Biovista is developing its own drug pipeline in multiple indications and is collaborating with the FDA on the prediction of adverse events, as well as with biopharmaceutical companies on indication expansion and de-risking of their portfolios (http://www.biovista.com ).

For further information please contact:

Dr. Aris Persidis, E: arisp@biovista.com


'/>"/>
SOURCE Biovista Inc.
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Biovista and the CFIDS Association of America Achieve Drug Repositioning Milestone with Pre-IND Meeting
2. Neue Publikation von Biovista Inc.: EMR-Daten bestätigen die Vorhersage von Big Data Analytics, dass Hypothyreose einen Risikofaktor für das Neuaufteten von Diabetes Mellitus darstellt
3. New Biovista Inc. Publication: EMR Data Confirm Big Data Analytics Prediction That Hypothyroidism is a Risk Factor for New-onset Diabetes Mellitus
4. Biovista Inc. gibt Zusammenarbeit mit Astellas Pharma zwecks Umpositionierung von Arzneimitteln bekannt
5. Pharmagen Announces First Quarter 2013 Results
6. Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year
7. Vasomedical Announces Financial Results for the First Quarter of 2013
8. TSI Announces 2013 Respiratory Protection Roadshow Training Dates and Locations
9. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
10. Active Life Announces $500K Follow On Series A Investment - Tech Coast Angels Re-up
11. Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/17/2019)... ... July 17, 2019 , ... Gwinnett Family Dental Care , located at ... complete dental care, including general and preventative care as well as restorative and ... of extensively trained dentists, Dr. Kell Gallaher, Dr. Jon Klevansky, Dr. Jason Klevansky, Dr. ...
(Date:7/17/2019)... ... July 17, 2019 , ... As the healthcare ... strategies to keep pathologists, laboratory professionals and residents on the forefront of the ... patient care. , Renowned Speakers Covering Crucial Topics , On September 11, ...
(Date:7/17/2019)... ... July 16, 2019 , ... ... has announced the Best Assisted Living Communities in New York City. The ... affordability and more.     , AssistedLiving.org used a unique selection process which involved ...
Breaking Medicine Technology:
(Date:7/17/2019)... (PRWEB) , ... July 17, 2019 , ... ... solutions to health plans participating in Medicare Advantage, Medicaid, and Marketplace programs is ... for Providers featuring Electronic Health Records (EHR) integration at the point ...
(Date:7/17/2019)... ... July 17, 2019 , ... It took just several small ... Martinez, MD, to relieve pressure on the nerves under Amber Walck’s scalp, and suddenly ... woman turned 30 last year, her debilitating headaches began without warning. About 39 ...
(Date:7/17/2019)... Ontario (PRWEB) , ... July 17, 2019 , ... ... management software and client engagement options for human services providers worldwide, has been ... , The CMAS program streamlines the procurement process for state and local government ...
(Date:7/17/2019)... SAN DIEGO (PRWEB) , ... July 17, 2019 , ... ... not become parents. Every Intended Parents’ story differs , but, in addition to ... their Surrogate. , Across the globe, more and more Intended Parents are electing to ...
(Date:7/17/2019)... (PRWEB) , ... July 17, 2019 , ... ... York State ( COMPA ) today announced that seven of its member Opioid ... the treatment of substance abuse and hepatitis C virus (HCV) with the goal ...
Breaking Medicine News(10 mins):